Trademarkia Logo

United Kingdom

£
Trademark Search
HERVOLUTION

View On IPO.GOV.UK

Registered

on 3 Feb 2024

Last Applicant/ Owned by

InPro Ther ApS

c/o Bio Innovation Institute, Ole Maaløes Vej 3

København, , 2200

Serial Number

UK00004010573 filed on 3rd Feb 2024

Registration Number

UK00004010573 registered on
26th Apr 2024

Correspondent Information

Abel & Imray LLP

Westpoint Building, James Street West

Bath,

BA1 2DA

HERVOLUTION

pharmaceuticals; medical and veterinary preparations; substances adapted for medical or veterinary use; vaccines and medicines for the treatment of ca Read More

Classification Information

Class [5]
Pharmaceutical Products

Pharmaceuticals; medical and veterinary preparations; Substances adapted for medical or veterinary use; Vaccines and medicines for the treatment of cancer, immune diseases, degenerative diseases, and senescence associated diseases; Viral-based immunotherapeutics, in particular for the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases.

Class [35]
Advertising, Business & Retail Services

Business management, organization and administration; business management of licences for pharmaceuticals, vaccines and medicines, such as viral-based immunotherapeutics, in particular for the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases; Import and export of pharmaceuticals, vaccines and medicines, such as viral-based immunotherapeutics, in particular for the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases; Retailing and wholesaling in shops and via global telematic networks of pharmaceuticals, vaccines and medicines, such as viral-based immunotherapeutics, in particular for the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases.

Class [42]
Computer & Software Services & Scientific Services

Research and development of pharmaceuticals, vaccines and medicines, such as viral-based immunotherapeutics, in particular for the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases; Clinical trials of pharmaceuticals, vaccines and medicines, such as viral-based immunotherapeutics, in particular for the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases; Medical, biological, and scientific research relating to the treatment of cancer, immune diseases, degenerative diseases and senescence associated diseases, in particular via immunotherapy.

Mark Details

Serial Number

UK00004010573

Mark Type

Word

Kind of mark

Individual